p38β and Cancer: The Beginning of the Road
Open Access
- 12 October 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (20) , 7524
Abstract
The p38 mitogen-activated protein kinase (MAPK) signaling pathway is implicated in cancer biology and has been widely studied over the past two decades as a potential therapeutic target. Most of the biological and pathological implications of p38MAPK signaling are often associated with p38α (MAPK14). Recently, several members of the p38 family, including p38γ and p38δ, have been shown to play a crucial role in several pathologies including cancer. However, the specific role of p38β (MAPK11) in cancer is still elusive, and further investigation is needed. Here, we summarize what is currently known about the role of p38β in different types of tumors and its putative implication in cancer therapy. All evidence suggests that p38β might be a key player in cancer development, and could be an important therapeutic target in several pathologies, including cancer.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (RTI2018-094093-B-I00)
- Fundacion Leticia Castillejo (N/A)
This publication has 121 references indexed in Scilit:
- p38β, A Novel Regulatory Target of Pokemon in Hepatic CellsInternational Journal of Molecular Sciences, 2013
- Signal‐dependent incorporation of MyoD–BAF60c into Brg1‐based SWI/SNF chromatin‐remodelling complexThe EMBO Journal, 2011
- Phosphorylation of Raptor by p38β Participates in Arsenite-induced Mammalian Target of Rapamycin Complex 1 (mTORC1) ActivationJournal of Biological Chemistry, 2011
- Genetic analysis of specific and redundant roles for p38α and p38β MAPKs during mouse developmentProceedings of the National Academy of Sciences, 2011
- Essential role of p18Hamlet/SRCAP‐mediated histone H2A.Z chromatin incorporation in muscle differentiationThe EMBO Journal, 2010
- Signal integration by JNK and p38 MAPK pathways in cancer developmentNature Reviews Cancer, 2009
- Integration of Protein Kinases mTOR and Extracellular Signal-Regulated Kinase 5 in Regulating Nucleocytoplasmic Localization of NFATc4Molecular and Cellular Biology, 2008
- A new p38 MAP kinase‐regulated transcriptional coactivator that stimulates p53‐dependent apoptosisThe EMBO Journal, 2007
- p38 kinase regulates epidermal growth factor receptor downregulation and cellular migrationThe EMBO Journal, 2006
- Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammationNature, 1997